Provided is a method of treating a proliferative disease, condition, or disorder in a subject by administering a combination of an inhibitor of p53 and MDM2 binding and an EGFR inhibitor. Various embodiments of the disclosed methods provide a synergistic
-
Page/Page column 166
(2016/01/29)
More Articles about upstream products of 31430-47-4